Halozyme Therapeutics shares owned by Washington Capital Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Washington Capital Management
from 13F filings
Historical chart of Washington Capital Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Washington Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Washington Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $349k | 7.3k | 47.81 |
| 2024-09-30 | $418k | 7.3k | 57.24 |
| 2024-06-30 | $566k | 11k | 52.36 |
| 2024-03-31 | $631k | 16k | 40.68 |
| 2023-12-31 | $573k | 16k | 36.96 |
| 2023-09-30 | $592k | 16k | 38.20 |
| 2023-06-30 | $559k | 16k | 36.07 |
| 2023-03-31 | $592k | 16k | 38.19 |
| 2022-12-31 | $711k | 13k | 56.90 |
| 2022-09-30 | $494k | 13k | 39.52 |
| 2022-06-30 | $550k | 13k | 44.00 |
| 2022-03-31 | $706k | 18k | 39.89 |
| 2021-12-31 | $667k | 17k | 40.18 |
More positions owned by Washington Capital Management
View all positions for Washington Capital Management